Place Your Advertisement Here. All ad revenues support the mission of the Epilepsy Therapy Project.
 
Thu, 2/9/2012

Welcome to the redesigned epilepsy.com

It is now easier and faster than ever to access news, articles and community content. With less clutter and an improved navigation system, your favorite content is now only a click away.

The new features include:

  • Streamlined design with less clutter to promote important content and sections
  • New slider masthead
  • New horizontal menu across the site to ease top level navigation
  • Re-designed content pages that are easier to navigate
  • Overall new, fresh look!

Place Your Advertisement Here

Take control of your epilepsy and seizures. Seizure management has never been easier.

TAKE CONTROL TODAY

Sign up for our Newsletter!



Pipeline Wiki Instructions – Add a New Entry

  • View/Print content

Register and Add a New Pipeline Wiki Entry

  1. Register on epilepsy.com: http://www.epilepsy.com/user/register
  2. Then, add a new Pipeline Wiki entry here: www.epilepsy.com/wiki

Below is a model outline of a pipeline entry. Please do not feel every entry needs to be comprehensive in its first iteration and do not be beholden to the model as we hope with your help to improve the framework for these entries. Drug and device sponsors and other members of the community are invited to help us develop new entries and expand and improve existing entries.

Model Outline

  1. Philanthropic Funding Provided by:
  2. Therapy Name
  3. Summary
  4. Community Ranking
    • Patient Impact
    • Probability of Success
    • Time to Market
    • Overall Assessment
  5. Therapy Description
  6. Sponsor
    • Company Name
    • Location (US; International)
    • Web Address
  7. Status
  8. Pharmacokinetics (If applicable)
  9. Dosing
  10. Formulations Under Development
  11. Indications
    • Epilepsy
    • Other
  12. Estimated Arrival In Market
  13. Trial Data
    • Patients Exposed and Timeframe
    • Phase 3
    • Phase 2 Trials
    • Phase 1 Summary (footnote)
  14. Adverse Events
  15. Animal Data
  16. Additional Sponsor Detail (as applicable)
    • For Private Companies: Please provide relevant details including VC and capital partners, ideally as available, data on total capital raised, current cash, # of employees, etc.
    • For Public Companies; the following data will be relevant
      • New York Stock Exchange Symbol
      • Market Capitalization
      • Revenues
      • Profits
      • Cash Flow from Operations (Net income + depreciation and amortization)
      • Net Cash (debt)
      • Other CNS Products Marketed by Sponsor
      • Other CNS Products in Sponsor Pipeline
      • Partnership status, Commercial Strategy (This is to be a commentary by ETP)
      • Development History of Compound (if applicable)
  17. Publications (from PubMed)
  18. Commentary (ETP Scientific and Business Advisory Boards, Community)
  19. Wiki Tags
    • Use “pipelinedrug” to feature therapy under the “Drugs” section
    • Use “pipelinedevice” to feature therapy under the “Devices” section
    • Use “pipelineother” to feature it under the “Other” section

If you have any questions or require assistance, please contact Joyce Cramer at: joyce@epilepsytherapyproject.org, or Kim Macher at: kim@epilepsytherapyproject.org.

None